Related Experiment Video
Updated: Sep 26, 2026

Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
Chorioretinitis induced by intravesical Bacillus Calmette-Guérin (BCG) instillations for urinary bladder carcinoma
Yan Guex-Crosier1, Line Chamot, Léonidas Zografos
1Hôpital Ophtalmique Jules Gonin, Lausanne, Schweiz. yan.guex@ophtal.vd.ch
Background:
We report the rare case of a chorioretinitis occurring after intravesical BCG instillation to cure in situ carcinoma.
History And Signs:
A 57-year-old man was treated for bladder carcinoma with BCG instillations. Visual acuity was 20/20 in the right eye and 20/40 in the left eye. Bilateral chorioretinitis was discovered three months after initiation of intravesical BCG therapy.
Therapy And Outcome:
No progression of ocular lesions could be seen after a 6 months therapy with rifampicin, isoniazide and ethambutol.
Conclusions:
BCG chorioretinitis is a rare complication that can be seen after intravesical BCG therapy. BCG is a live attenuated strain of Mycobacterium bovis. Two mechanisms can be proposed as the origin of ocular inflammation: a local immune response or a direct choroidal mycobacterial infection.
Related Concept Videos
Urinary Tract Infection II: Pathophysiology
Urinary Tract Infection III: Diagnostic Studies and Interprofessional Care
Imaging Studies VI: Voiding Cystourethrography and Cystography
